Histone modification profiling in breast cancer cell lines highlights commonalities and differences among subtypes
- PMID: 29458327
- PMCID: PMC5819162
- DOI: 10.1186/s12864-018-4533-0
Histone modification profiling in breast cancer cell lines highlights commonalities and differences among subtypes
Abstract
Background: Epigenetic regulators are frequently mutated or aberrantly expressed in a variety of cancers, leading to altered transcription states that result in changes in cell identity, behavior, and response to therapy.
Results: To define alterations in epigenetic landscapes in breast cancers, we profiled the distributions of 8 key histone modifications by ChIP-Seq, as well as primary (GRO-seq) and steady state (RNA-Seq) transcriptomes, across 13 distinct cell lines that represent 5 molecular subtypes of breast cancer and immortalized human mammary epithelial cells.
Discussion: Using combinatorial patterns of distinct histone modification signals, we defined subtype-specific chromatin signatures to nominate potential biomarkers. This approach identified AFAP1-AS1 as a triple negative breast cancer-specific gene associated with cell proliferation and epithelial-mesenchymal-transition. In addition, our chromatin mapping data in basal TNBC cell lines are consistent with gene expression patterns in TCGA that indicate decreased activity of the androgen receptor pathway but increased activity of the vitamin D biosynthesis pathway.
Conclusions: Together, these datasets provide a comprehensive resource for histone modification profiles that define epigenetic landscapes and reveal key chromatin signatures in breast cancer cell line subtypes with potential to identify novel and actionable targets for treatment.
Keywords: Breast cancer subtypes; Chromatin states; Epigenetics; Histone modifications.
Conflict of interest statement
Ethics approval and consent to participate
Not applicable. This work does not include human subjects, experiments with animals or plants.
Consent for publication
Not applicable.
Competing interests
All authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Figures



Similar articles
-
Immunohistochemical Profiling of Histone Modification Biomarkers Identifies Subtype-Specific Epigenetic Signatures and Potential Drug Targets in Breast Cancer.Int J Mol Sci. 2025 Jan 17;26(2):770. doi: 10.3390/ijms26020770. Int J Mol Sci. 2025. PMID: 39859484 Free PMC article.
-
A novel subtype classification and risk of breast cancer by histone modification profiling.Breast Cancer Res Treat. 2016 Jun;157(2):267-279. doi: 10.1007/s10549-016-3826-8. Epub 2016 May 13. Breast Cancer Res Treat. 2016. PMID: 27178334
-
Integration of microRNA signatures of distinct mammary epithelial cell types with their gene expression and epigenetic portraits.Breast Cancer Res. 2015 Jun 18;17(1):85. doi: 10.1186/s13058-015-0585-0. Breast Cancer Res. 2015. PMID: 26080807 Free PMC article.
-
Detection Methods for Epigenetic Mechanisms in Breast Cancer.Adv Exp Med Biol. 2024;1465:99-103. doi: 10.1007/978-3-031-66686-5_7. Adv Exp Med Biol. 2024. PMID: 39586996 Review.
-
Chromatin Organization and Transcriptional Programming of Breast Cancer Cell Identity.Endocrinology. 2023 Jun 26;164(8):bqad100. doi: 10.1210/endocr/bqad100. Endocrinology. 2023. PMID: 37394919 Free PMC article. Review.
Cited by
-
Analysis of opposing histone modifications H3K4me3 and H3K27me3 reveals candidate diagnostic biomarkers for TNBC and gene set prediction combination.BMB Rep. 2020 May;53(5):266-271. doi: 10.5483/BMBRep.2020.53.5.045. BMB Rep. 2020. PMID: 32317088 Free PMC article.
-
Opposing Functions of BRD4 Isoforms in Breast Cancer.Mol Cell. 2020 Jun 18;78(6):1114-1132.e10. doi: 10.1016/j.molcel.2020.04.034. Epub 2020 May 23. Mol Cell. 2020. PMID: 32446320 Free PMC article.
-
Roles of AFAP1-AS1 in Gynecology and Urogenital System.Curr Pharm Des. 2024;30(8):639-647. doi: 10.2174/0113816128286229240129090915. Curr Pharm Des. 2024. PMID: 38347771 Review.
-
Epigenetic alterations in canine mammary cancer.Genet Mol Biol. 2022 Oct 24;45(3 Suppl 1):e20220131. doi: 10.1590/1678-4685-GMB-2022-0131. eCollection 2022. Genet Mol Biol. 2022. PMID: 36279498 Free PMC article.
-
Quantitative analysis of non-histone lysine methylation sites and lysine demethylases in breast cancer cell lines.bioRxiv [Preprint]. 2024 Sep 22:2024.09.18.613658. doi: 10.1101/2024.09.18.613658. bioRxiv. 2024. Update in: J Proteome Res. 2025 Feb 07;24(2):550-561. doi: 10.1021/acs.jproteome.4c00685. PMID: 39345446 Free PMC article. Updated. Preprint.
References
-
- Rosenbloom K. R., Dreszer T. R., Pheasant M., Barber G. P., Meyer L. R., Pohl A., Raney B. J., Wang T., Hinrichs A. S., Zweig A. S., Fujita P. A., Learned K., Rhead B., Smith K. E., Kuhn R. M., Karolchik D., Haussler D., Kent W. J. ENCODE whole-genome data in the UCSC Genome Browser. Nucleic Acids Research. 2009;38(Database):D620–D625. doi: 10.1093/nar/gkp961. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases